Opipramol Inhibits Lipolysis in Human Adipocytes without Altering Glucose Uptake and Differently from Antipsychotic and Antidepressant Drugs with Adverse Effects on Body Weight Control

Pharmaceuticals
Christian CarpénéMaria José Garcia-Barrado

Abstract

Treatment with several antipsychotic drugs exhibits a tendency to induce weight gain and diabetic complications. The proposed mechanisms by which the atypical antipsychotic drug olanzapine increases body weight include central dysregulations leading to hyperphagia and direct peripheral impairment of fat cell lipolysis. Several investigations have reproduced in vitro direct actions of antipsychotics on rodent adipocytes, cultured preadipocytes, or human adipose tissue-derived stem cells. However, to our knowledge, no such direct action has been described in human mature adipocytes. The aim of the present study was to compare in human adipocytes the putative direct alterations of lipolysis by antipsychotics (haloperidol, olanzapine, ziprazidone, risperidone), antidepressants (pargyline, phenelzine), or anxiolytics (opipramol). Lipolytic responses to the tested drugs, and to recognized lipolytic (e.g., isoprenaline) or antilipolytic agents (e.g., insulin) were determined, together with glucose transport and amine oxidase activities in abdominal subcutaneous adipocytes from individuals undergoing plastic surgery. None of the tested drugs were lipolytic. Surprisingly, only opipramol exhibited substantial antilipolytic properties in ...Continue Reading

References

Jan 1, 1988·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H R BetschartM H Bickel
Jan 1, 1997·Archives of Biochemistry and Biophysics·H KimR R Ramsay
Jun 18, 1998·Annals of the New York Academy of Sciences·C CarpénéM Lafontan
Jun 28, 2000·Biopharmaceutics & Drug Disposition·M AravagiriS R Marder
Apr 16, 2003·European Journal of Pharmacology·Virgile VisentinChristian Carpéné
Nov 18, 2004·Pharmacopsychiatry·W E MüllerC Gentsch
Jul 16, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Katherine A RobinsonMaria G Buse
Apr 29, 2006·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Dominique Langin
Jul 11, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Helliner S VestriW Timothy Garvey
Jul 27, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Li-Hung YangYen-Hui Chen
Mar 14, 2008·Trends in Endocrinology and Metabolism : TEM·Max LafontanJean Galitzky
Feb 10, 2009·Molecular Pharmacology·Françoise ChicheBruno Fève
Jan 13, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·H G ShertzerM B Genter
Jul 21, 2010·Neurochemistry International·Takahira YamauchiAkio Wanaka
Apr 23, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Martien WampersMarc De Hert
Aug 16, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Andréa L SertiéWagner F Gattaz
Jan 15, 2013·Journal of Physiology and Biochemistry·Saioa Gomez-ZoritaChristian Carpéné
Feb 16, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Mee-Sook SongGlen B Baker
Jul 16, 2014·Biochemical and Biophysical Research Communications·Anitta K SárváriZoltán Balajthy
Oct 17, 2015·Biochemical and Biophysical Research Communications·Satomi NimuraHiroyuki Itabe
May 4, 2017·World Journal of Diabetes·Christian CarpénéXavier Testar
Mar 28, 2018·The Journal of Pharmacology and Experimental Therapeutics·Natasha D BushDavid C Wright
Mar 28, 2018·British Journal of Pharmacology·Christian CarpénéJean Galitzky
May 13, 2018·Pharmaceuticals·Fernando DurãesEmília Sousa
Jul 5, 2018·British Journal of Pharmacology·Csilla Terézia NagyPéter Ferdinandy
Jul 25, 2018·Journal of Physiology and Biochemistry·Christian CarpénéAlexia Zakaroff-Girard
Sep 28, 2018·International Journal of Molecular Sciences·Christian CarpénéJosep Mercader
Oct 9, 2018·The Journal of Clinical Investigation·Donghong CuiRichard Bucala
Mar 5, 2019·Clinical Neuropharmacology·Verena RozanskiJohannes Schwarz

❮ Previous
Next ❯

Methods Mentioned

BETA
deamination

Software Mentioned

Excel
Powerpoint
GraphPad Prism

Related Concepts

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Die Medizinische Welt
B Herrmann, D von Kobyletzki
Psychiatria Danubina
Krzysztof KrystaIrena Krupka-Matuszczyk
Polish Journal of Pharmacology and Pharmacy
G SkuzaH Sowińska
Journal of the American Geriatrics Society
E A KENT, P WEINSAFT
Nederlands tijdschrift voor geneeskunde
A C van VlietJ H Wilson
© 2021 Meta ULC. All rights reserved